Search

Your search keyword '"Pons-Estel, B. A."' showing total 144 results

Search Constraints

Start Over You searched for: Author "Pons-Estel, B. A." Remove constraint Author: "Pons-Estel, B. A."
144 results on '"Pons-Estel, B. A."'

Search Results

1. POS0741 IMPACT OF ACTIVE LUPUS NEPHRITIS ON THE QUALITY OF LIFE OF PATIENTS FROM A LATIN AMERICAN LUPUS COHORT

2. POS0114 LUPUS NEPHRITIS AND RESPONSE TO TREATMENT IN LATIN AMERICA

3. POS1016 THE IMPACT OF ACTIVE LUPUS NEPHRITIS ON WORK PRODUCTIVITY IN PATIENTS FROM A LATIN AMERICAN LUPUS COHORT

4. AB1046 EVALUATION OF ACCRUAL DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: COMPARISON OF DATA FROM THE NATIONAL CROSS-SECTIONAL AND PROSPECTIVE LUPUS REGISTRY

5. POS0974 CARDIOVASCULAR OUTCOMES OF ANTI-TNF ALFA AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS. REAL WORLD EVIDENCE AND INSIGHTS OF BIOBADASAR 3.0 REGISTRY

6. POS1494 HOSPITALIZATIONS DUE TO INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS: CAUSES AND ASSOCIATED FACTORS

7. AB0618 DELAY TO DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS AND ITS IMPACT ON CUMULATIVE DAMAGE AND MORTALITY: DATA FROM A MULTIETHNIC LATIN AMERICAN COHORT

8. AB0578 LATIN-AMERICAN SYSTEMIC LUPUS ERYTHEMATOSUS CLUSTERS

9. AB1666 CLUSTER ANALYSIS TO IDENTIFY PATIENT GROUPS AND ASSESS THE PRESENCE OF ADVERSE EVENTS. REAL WORLD EVIDENCE FROM THE BIOBADASAR 3.0 REGISTRY

10. AB0580 PREGNANCY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): DATA FROM A MULTIETHNIC, MULTINATIONAL LATIN AMERICAN COHORT

11. POS0169 PREDICTORS OF FIRST HOSPITALIZATIONS DUE TO DISEASE ACTIVITY AND INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

12. OP0231 EVALUATION OF NON-CRITERIA MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH SYSTEMIC LUPUSERYTHEMATOSUS ACCORDING TO ANTI-PHOSPHOLIPID ANTIBODY PROFILE

14. POS0660 SURVIVAL AND SAFETY OF BIOLOGICAL AND TARGETED SYNTHETIC THERAPIES. 10 YEARS OF REAL-LIFE DATA. BIOABASAR 3.0 REGISTRY

15. POS0655 SURVIVAL AND SAFETY OF BIOLOGICAL AND TARGETED SYNTHETIC THERAPIES AS REGARDS TO AGE GROUPS. BIOBADASAR 3.0 REGISTRY.

16. POS0707 POTENTIAL USE OF BELIMUMAB IN LUPUS PATIENTS FROM ARGENTINE COHORT ACCORDING DISEASE ACTIVITY STATE

17. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus

19. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis

20. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort

24. OP0296 THE 2021 DORIS DEFINITION OF REMISSION IN SLE – FINAL RECOMMENDATIONS FROM AN INTERNATIONAL TASK FORCE

25. OP0289 LLDAS (LOW LUPUS DISEASE ACTIVITY STATE), LOW DISEASE ACTIVITY (LDA) AND REMISSION (ON- OR OFF-TREATMENT) PREVENT DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN A MULTINATIONAL MULTICENTER COHORT

26. No evidence of association between genetic variants of the PDCD1 ligands and SLE

28. Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina

31. AB0428 ASSOCIATION BETWEEN GEOGRAPHIC AND CLIMATOLOGICAL CONDITIONS AND CUTANEOUS MANIFESTATIONS IN LUPUS PATIENTS FROM THE SPANISH RHEUMATOLOGY SOCIETY LUPUS REGISTRY (RELESSER) AND ARGENTINE RHEUMATOLOGY SOCIETY LUPUS REGISTRY (RELESSAR) COHORT

32. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

33. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context

35. AB0297 Predictors of an inadequate response to treatment in latin american patients with early rheumatoid arthritis

37. Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial

38. Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort

39. Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL)

40. 255 Predictors of remission and low lupus disease activity status (lldas): data from a multi-ethnic, multinational latin american lupus cohort

41. 192 Protective effect of antimalarials on the risk of damage accrual in systemic lupus erythematosus

43. CARDIOVASCULAR OUTCOMES OF ANTI-TNF ALFA AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS. REAL WORLD EVIDENCE AND INSIGHTS OF BIOBADASAR 3.0 REGISTRY.

44. Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort

45. SAT0488 Tuberculosis in A Registry of Rheumatic Patients Treated with Biological Drugs

46. Características de los tratamientos biológicos en enfermedades reumáticas en Argentina: quinto informe del registro BIOBADASAR

47. Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

48. THU0016 Trans-Ethnic Genome-Wide Analysis Reveals MHC Variability in Rheumatoid Arthritis Genetic Susceptibility

49. Lupus in Latin-American patients: lessons from the GLADEL cohort

50. Functional variants in the B-cell gene bank1 are associated with SLE

Catalog

Books, media, physical & digital resources